Financial SPAC HCM Acquisition Prices US$250 Million IPO

Special purpose acquisition company HCM Acquisition Corp (Nasdaq: HCMAU) started trading publicly on the Nasdaq Global Market today. The company is seeking to raise US$250 million in its initial public offering.

The offering consists of 25.0 million company units priced at US$10.00 per unit. Each unit is composed of one Class A common share and one-half of a purchase warrant. Each whole warrant is redeemable for one Class A common share at US$11.50 per share.

The company units trade on the Nasdaq big board under the symbol “HCMAU”. Once the securities separate, the company shares and warrants will trade under the ticker symbols “HCMA” and “HCMAW”, respectively.

The proposed offering is being managed by Cantor Fitzgerald & Co. as the sole bookrunner. The underwriters were granted a 45-day over-allotment option to purchase additional 3.75 million company units at the same IPO price.

The blank check company is led by alternative investment firm Hondius Capital Management alums Shawn Matthews and James Bond as CEO and president, respectively. The firm said it intends to search for businesses providing “disruptive technology or innovations within the financial services industry.”


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Silver’s Next Move May Be Built on a Much Stronger Base | Mani Alkhafaji – First Majestic Silver

Guanajuato Silver Q1 Earnings: They Finally Post Positive Net Income

We’re in a New Era of Gold Price Discovery | Ryan King – Equinox Gold

Recommended

Mercado Minerals Drills 1,120 g/t Silver Equivalent Over 1.20 Metres At Copalito

Goliath Resources Targets Expansion, Motherlode Source in 50,000 Metre Surebet Drill Program

Related News

Biotech Firm CinCor Pharma Kicks Off Nasdaq IPO Roadshow

Clinical-stage biopharmaceutical company CinCor Pharma, Inc. is setting its sights on trading at the Nasdaq...

Tuesday, January 4, 2022, 02:36:00 PM

SPAC Patria Latin American Opportunity Acquisition Prices US$200 Million IPO

Special purpose acquisition company Patria Latin American Opportunity Acquisition Corp. (Nasdaq: PLAOU) started trading publicly...

Thursday, March 10, 2022, 02:21:00 PM

Tech SPAC Athena Technology Acquisition II Looks To Raise US$250 Million In IPO

Blank check company Athena Technology Acquisition Corp. II (NYSE: ATEK.U) went public today on the...

Friday, December 10, 2021, 02:11:00 PM

SpaceX’s Prospectus Is Coming—and the Hype Is Already Ahead of the Numbers

SpaceX is about to file its public prospectus — the first time the world will...

Monday, May 18, 2026, 05:42:52 AM

Chinese Medical Manufacturer Meihua International Prices Downsized US$36 Million Nasdaq IPO

Chinese disposable medical devices manufacturer Meihua International Medical Technologies Co. (Nasdaq: MHUA) announced on Wednesday...

Thursday, February 17, 2022, 02:21:00 PM